Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of a short course of neoadjuvant hormonal therapy on the response to subsequent androgen suppression in prostate cancer patients with relapse after radiotherapy: a secondary analysis of the randomized protocol RTOG 86-10.
Shipley WU, Lu JD, Pilepich MV, Heydon K, Roach M, Wolkov HB, Sause WT, Rubin P, Lawton CA, Machtay M. Shipley WU, et al. Among authors: sause wt. Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1302-10. doi: 10.1016/s0360-3016(02)03052-3. Int J Radiat Oncol Biol Phys. 2002. PMID: 12459350 Clinical Trial.
Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10.
Shipley WU, Desilvio M, Pilepich MV, Roach M 3rd, Wolkov HB, Sause WT, Rubin P, Lawton CA. Shipley WU, et al. Among authors: sause wt. Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1162-7. doi: 10.1016/j.ijrobp.2005.09.039. Epub 2006 Jan 19. Int J Radiat Oncol Biol Phys. 2006. PMID: 16427211 Clinical Trial.
A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04).
Bradley JD, Scott CB, Paris KJ, Demas WF, Machtay M, Komaki R, Movsas B, Rubin P, Sause WT. Bradley JD, et al. Among authors: sause wt. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1173-9. doi: 10.1016/s0360-3016(01)02797-3. Int J Radiat Oncol Biol Phys. 2002. PMID: 11955727 Clinical Trial.
Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience.
Machtay M, Hsu C, Komaki R, Sause WT, Swann RS, Langer CJ, Byhardt RW, Curran WJ. Machtay M, et al. Among authors: sause wt. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):667-71. doi: 10.1016/j.ijrobp.2005.03.037. Epub 2005 May 31. Int J Radiat Oncol Biol Phys. 2005. PMID: 15927409 Clinical Trial.
Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group.
Machtay M, Bae K, Movsas B, Paulus R, Gore EM, Komaki R, Albain K, Sause WT, Curran WJ. Machtay M, et al. Among authors: sause wt. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):425-34. doi: 10.1016/j.ijrobp.2010.09.004. Epub 2010 Oct 25. Int J Radiat Oncol Biol Phys. 2012. PMID: 20980108 Free PMC article. Clinical Trial.
Correlation of survival with quantitative tissue staining of prostate specific acid phosphatase in patients with prostate carcinoma by using microscopic image analysis: a preliminary report of correlative studies on RTOG protocols 75-06, 77-06, and 83-07.
Zhou R, Sause WT, Hammond EH, Rubin P, Perez C, Pilepich MV, Asbell SD, Parker DL. Zhou R, et al. Among authors: sause wt. Int J Radiat Oncol Biol Phys. 1995 Nov 1;33(4):823-9. doi: 10.1016/0360-3016(95)02015-3. Int J Radiat Oncol Biol Phys. 1995. PMID: 7591889 Free article.
Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group.
Pilepich MV, Krall JM, al-Sarraf M, John MJ, Doggett RL, Sause WT, Lawton CA, Abrams RA, Rotman M, Rubin P, et al. Pilepich MV, et al. Among authors: sause wt. Urology. 1995 Apr;45(4):616-23. doi: 10.1016/s0090-4295(99)80053-3. Urology. 1995. PMID: 7716842 Clinical Trial.
Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology Group.
Lawton CA, Winter K, Byhardt R, Sause WT, Hanks GE, Russell AH, Rotman M, Porter A, McGowan DG, DelRowe JD, Pilepich MV. Lawton CA, et al. Among authors: sause wt. Int J Radiat Oncol Biol Phys. 1997 Jul 15;38(5):931-9. doi: 10.1016/s0360-3016(97)00288-5. Int J Radiat Oncol Biol Phys. 1997. PMID: 9276357 Clinical Trial.
Ten-year outcomes for pathologic node-positive patients treated in RTOG 75-06.
Hanks GE, Buzydlowski J, Sause WT, Emami B, Rubin P, Parsons JA, Russell AH, Byhardt RW, Earle JD, Pilepich MV. Hanks GE, et al. Among authors: sause wt. Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):765-8. doi: 10.1016/s0360-3016(97)00921-8. Int J Radiat Oncol Biol Phys. 1998. PMID: 9531359 Free article.
136 results